HBI Deals+Insights / M&A/IPOs
Shares in pan-European elderly care group Korian dived by 10% after it announced a €400m capital raise to fund the acquisition of France's third-largest psychiatry provider Inicea from infrastructure investor Antin. But did it pay over-the-odds and do all shareholders support the capital raise? We talk to an analyst from Bryan, Garnier & Co.